Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis;Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile

Minerva Medica

Volumn 98, Issue 1, 2007, Pages 53-68

  Rossini, M ^a   Viapiana, O ^a   Idolazzi, L ^a   Fracassi, E ^a   Gatti, D ^a   Adami, S ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Calcidiol; Osteoporosis; Vitamin D 25 hydroxycholecalciferol

Indexed keywords

CALCIFEDIOL; VITAMIN D;

HUMAN; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; REVIEW; RISK FACTOR; SENILE OSTEOPOROSIS; VITAMIN DEFICIENCY;

BONE DENSITY CONSERVATION AGENTS; CALCIFEDIOL; CALCITRIOL; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 34249686530     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Holick MF. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 92-8.
2. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet radiation. Lancet 1989;2:1104-5.
3. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:87-98.
4. Holick MF. Calciotropic hormones and the skin: a millennium perspective. J Cell Biochem 2003;88:296-307.
5. Holick MF. New horizons for the 21st century. Am J Clin Nutr 1994;60:619-30.
6. Bouillon R. Vitamin D: from photosynthesis, metabolism and action to clinical applications. In: Degroot LL, Jameson JL, editors. Endocrinology. 4th ed. Philadelphia, PA: WB Saunders Co.; 2001. vol. 2. p. 1009-28.
7. De Luca H. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988;2:224-36.
8. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990;51:1075-81.
9. Van den Berg H. Bioavailability of vitamin D. Eur J Clin Nutr 1997;51:76-9.
10. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
11. Smith JE, Goodman DS. The turnover and trasport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest 1971;50:2159-67.
12. Haddad JG Jr, Rojanasathit S. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab 1976;42:284-90.
13. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC. 1,25 (OH)2D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992;41:231-40.
14. Ebeling PR, Sandgren ME, Di Magno EP, Lane AW, De Luca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25- dihydroxyvitamin D3 and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab 1992;75:176-82.
15. Baker MR, McDonnell, Peacock M, Nordin BEC. Plasma 25-hydroxyvitamin D concentrations in patients with fractures of the femoral neck. BMJ 1979;1:589.
16. Benhamou CL, Chappard D, Gauvain JB, Popelier M, Roux C, Picaper G et al. Hyperparathyroidism in proximal femur fractures: biological and histomorphometric study in 21 patients over 75 years old. Clin Rheumatol 1991;10:144-50.
17. Komar L, Nieves J, Cosman F, Rubin A, Shen V, Lindsay R. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 1993;41:1057-64.
18. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;281:1505-11.
19. Lips P, Netelenbos C, Jongen MJM, van Ginkel FC, Althuis AL, van Schaik CL et al. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 1982;4:85-93.
20. Lips P, van Ginkel FC, Jongen MJM, Rubertus F, van der Vijgh WJF, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr 1987;46:1005-10.
21. Lips P, Obrant KJ. The pathogenesis and treatment of hip fractures. Osteoporos Int, 1991;1:218-31.
22. Meller Y, Kestenbaum RS, Galinsky D, Shany S. Seasonal variations in serum levels of vitamin D metabolism and parathormone in geriatric patients with fractures in southern Israel. Isr J Med Sci 1986;22:8-11.
23. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36:1014-31.
24. Von Knorring J, Slatis P, Weber TH, Helenius T. Serum levels of 25-hydroxyvitamin D, 24-25-dihydroxyvitamin d and parathyroid hormone in patients with femoral neck fracture in southern Finland. Clin. Endocrinol 1982;17:189-94.
25. Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17:1608-14.
26. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976;1:626-7.
27. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986;7:434-48.
28. Mowè M, Haug E, Bahmer T. Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriac Soc 1999;47:220-6.
29. Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vohthein R, Perrig-Chiello P et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999;80:54-8.
30. Pfeifer M, Begerow B, Minne HW, Schlotthauer T, Pospeschill M, Scholz M et al. VitaminD status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 2001;109:87-92.
31. Zamboni M, Zoico E, Tosoni P, Zielonghi A, Bortolani A, Maggi S et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol Med Sci 2002;57A:M7-M11.
32. Dhesi JK, Beame LM, Moniz C, Hurley MV, Jackson SH, Swift CG et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002;17:891-7.
33. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-72.
34. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005;330:524-6.
35. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25 hydroxy vitamin D levels, physical activity, muscle strenght and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 2005;16:1425-31.
36. Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinol Jpn 1979;26:65-72.
37. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.
38. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY et al. Effect of vitamin D on falls. JAMA 2004;291:1999-2006.
39. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004;52:230-6.
40. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
41. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-71.
42. Sieg J, Sieg A, Dreyhaupt J, Schmidt-Gayk H. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res 2006;26:2729-33.
43. McCullough ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ et al. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II. Cancer Epidemiol Biomarkers Prev 2005;14:2898-904.
44. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2006;15:1427-37.
45. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006;15:1688-95.
46. Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 2006;31:512-4.
47. Luscombe CJ, Fryer AA, French ME, Liu S, Saxby MF, Jones PW et al. Ultraviolet radiation exposure may protect against prostate cancer. Lancet 2001;358:641-2.
48. Mohr SB, Gorham ED, Garland CF, Grant WB, Garland FC. Are low ultraviolet B and-high animal protein intake associated with risk of renal cancer? Int J Cancer 2006;119:2705-9.
49. Holick MF. Clinical efficacy of 1,25- dihydroxyvitamin D3 and analogues in the treatment of psoriasis. Retinoids 1998;14:12-7.
50. Guyton KZ, Kensler YW, Posner GH. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol 2001;41:421-42.
51. Scragg R, Jackson R, Holdaway JM, Lim T, Beaglehole R. Myocardial Infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559-63.
52. Li Y, Kong J, Wei M, Chen ZF, Liu S, Cao LP. 1,25- dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38.
53. Hypponen E, Laara E, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
54. Munger KL, Zhang, SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5.
55. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50:72-7.
56. McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among partecipants in the Framingham Study. Ann Intern Med 1996;125:353-9.
57. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081-2.
58. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
59. Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 2003;77:504-11.
60. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C et al. Effects of calcium, and vitamin D on risk of falls: a randomized controlled study. J Bone Miner Res 2003;18:343-51.
61. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006;166:424-30.
62. Flicker L, Macinnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005;53:1881-8.
63. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005; CD000227.
64. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N et al. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:560-9.
65. Richy F, Ethgen O, Bruyere O, Reginster JY. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 2004;15:301-10.
66. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation. A meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
67. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8.
68. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003-9.
69. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
70. Rossini M, Viapiana O, Gatti D, James G, Girardello S, Adami S. La correzione dell'ipovitaminosi'D nel lungo termine: confronto tra diverse modalità di sommin-strazione di vitamina D nella pratica clinic. Minerva Med 2005;96 Suppl 1:1-7.
71. Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L et al. Determinants of adherence to osteoporosis treatment in Clinical practice. Osteoporos Int 2006;17:914-21.
72. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R et al. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO Study. J Bone Miner Res 2006;21:1565-70.
73. Mastaglia SR, Pellegrini GG, Mandalunis PM, Gonzales Chaves MM, Friedman SM, Zeni SN. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats. Bone 2006;39:837-44.
74. Johnson MA, Kimlin MG. Vitamin D, Aging, and the 2005 Dietary Guidelines for Americans. Nutr Rev 2006;64:410-21.
75. Gartner LM, Greer FR. Prevention of rickets and vitamin D deficiency: new guidelines: for vitamin D intake. Pediatrics 2003;111:908-10.
76. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board Institute of Medicine, National Academy of Sciences. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 2000.
77. Weaver CM, Fleet, JC. Vitamin D requirements: current and future. Am J Clin Nutr 2004;80 Suppl:1735S-9S.
78. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.
79. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001;86:3086-90.
80. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294:2336-41.
81. Barger-Lux MJ, Heaney RP, Dowell S, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy meni Osteoporos Int 1998;8:222-30.
82. Heaney RP. Nutrition and osteoporosis. In: Favus MJ editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5 ed. Washington, DC: American Society for Bone and Mineral Research; 2003. p. 352-4.
83. Need AG, O'Loughlin PD, Morris HA, Horowitz M, Nordin BEC. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocr Metab 2004;89:1646-9.
84. Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem. Mol Biol 2004;89-90:575-9.
85. Dawson Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6.
86. Bischoff-Ferrari HA, Giovannucci E, Willet WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
87. Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 1992;326:1173-7.
88. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington DC: National Academy Press; 1997.
89. Rossini M, Perbellini S, Lazzarin M, Adami S, Bertoldo F, Lo Cascio V. Incidenza di ipovitaminosi D nel Nord Italia. Ital J Min Elect Metab 1990;4:13-7.
90. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr 1999;81:133-7.
91. Bettica P, Bevilacqua M, Vago T, Norbiato G. High prevalence of hypovitaminosis D among free-living post-menopausal women referred to an oteoporosis outpatient clinic in northern Italy for initial screening. Osteoporosis Int 1999;9:226-9.
92. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 2001;12:1026-30.
93. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 2003;14:577-82.
94. Rossini M. Vitamin D inadequacy: the Italian picture, Clin Cases Min Bone Metab 2006;3:43-9.
95. Van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, Moreiras O et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207-10.
96. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-21.
97. Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M et al. 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol 2005;60A:1414-9.
98. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-24.
99. Bayly JR, Hollands RD, Riordan-Jones SE, Yemm SJ, Brough-Williams I, Thatcher M et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 2006;22:131-7.
100. Tjellesen L, Hummer L, Christiansen C, Rødbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986;1:407-13.
101. Trang HM, Cole DEC, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence thet vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:854-8.
102. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocr Metab 2004;89:5387-91.
103. Baird DP, Hordon R, Longcope C, Tait JF. Steroid hormone dynamics under steady state conditions. Recent Prog Horm Res 1969;25:611-64.
104. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem 1984;21:81-6.
105. Hollis BW, Frank NE. Quantitation of vitamin D2, vitamin D3, 25-hydroxyvitamin D2, and 25-hydroxyvitamin D3 in human milk. Methods Enzymol 1986;123:167-76.
106. Haddad JG, Matsuoka LT, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993;91:2552-5.
107. Whyte MP, Haddad JG, Watters DD, Stamp TC. Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. J Clin Endocrinol Metab 1979;48:906-11.
108. Stephens WP, Klimiuk PS, Berry JL, Mawer EB. Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet 1981;28:1199-202.
109. Trivedi DP, Doll R, Khau KT. Effect of four monthly vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469-72.
110. Khaw KT, Scragg R, Murphy S. Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr 1994;59:1040-4.
111. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19:1221-30.
112. Rapuri PB, Gallagher JC, Haynatzki G. Effect of vitamin D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter. Calcif Tissue Int 2004;74:150-6.
113. Rossini M, Alberti V, Flor L, Masiero L, Giannini S, Gatti D et al. Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women: a community primary prevention study. Aging Clin Exp Res 2004;16:432-6.
114. Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183:10-2.
115. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
116. Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ. Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther 2002;24:1871-86.
117. Kendler D, Kung AWC, Fuleihan GEH, Gonzales JGG, Gaines KA, Verbruggen N et al. Patients with osteoporosis prefer once weekly to once daily dosing with alendronate. Maturitas 2004;48:243-51.
118. Maislos M, Silver J, Fainaru M. Intestinal absorption of vitamin D sterols: differential absorption into lymph and portal blood in the rat. Gastroenterology 1981;80: 1528-34.
119. Davies M, Mawer EB, Klass HJ, Lumb GA, Berry JL, Warnes TW. Vitamin deficiency, osteomalacia and primary biliary cirrhosis. Digestive Dis Sci 1983;28:145-52.
120. Compston JE, Merrett AL, Hammett FG, Magill P. Comparison of the appearance of radiolabelled vitamin D3 and 25-hydroxyvitamin D3 in the chylomicron fraction of plasma after oral administration in man. Clin Sci 1981;60:241-3.
121. Sitrin MD, Bengoa JM. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in chronic cholestatic liver disease. Am J Clin Nutr 1987;46:1011-5.
122. Coen G, Taccone Gallucci M, Bianchini G, Lucentini G, Gallucci G, Bianchi AR et al. Behavior of serum 25-hydroxycholecalciferol in humans after administration of vitamin D and 25-OHD3. Boll Soc Ital Biol Sper 1979;55:2051-6.
123. Vieth R. The mechanisms of vitamin D toxicity. Bone Miner 1990;11:267-72.